MedTrace Logo

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction

NCT00567814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2008-12-31

No results posted yet for this study

Summary

Subjects will be randomly assigned to receive either one of the two potential dose combinations of the study medications or placebo over 6 weeks. The study will include twice weekly visits to the research clinic for laboratory studies, safety assessments and urine drug screens. Subjects will also be questioned regarding drug craving and mood symptoms.

Conditions

  • Cocaine Dependence
  • Cocaine Addiction

Interventions

DRUG

Metyrapone

Twice daily

DRUG

Oxazepam

Twice Daily

DRUG

Placebo

Twice daily

Sponsors & Collaborators

  • Embera NeuroTherapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Anita S Kablinger, MD · LSU Health Sciences Center - Shreveport

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567814 on ClinicalTrials.gov